Colon Cancer: Overview on Improved Therapeutic Potential of Plant-Based Compounds Using Nanotechnology

Colon cancer (CC) is the third most frequent neoplasm, with a considerably high mortality rate. Due to the side effects of conventional forms of CC treatment (surgery, chemotherapy, and radiotherapy), several studies have focused on the use of medicinal plant derivatives to provide a green therapy f...

Full description

Saved in:
Bibliographic Details
Main Authors: Manuel López-Cabanillas Lomelí, Alexandra Tijerina-Sáenz, David Gilberto García-Hernández, Marcelo Hernández-Salazar, Rogelio Salas García, José Luis González-Llerena, María Julia Verde-Star, Anthonny Cordero-Díaz, Michel Stéphane Heya
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Scientia Pharmaceutica
Subjects:
Online Access:https://www.mdpi.com/2218-0532/93/1/1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849339674097614848
author Manuel López-Cabanillas Lomelí
Alexandra Tijerina-Sáenz
David Gilberto García-Hernández
Marcelo Hernández-Salazar
Rogelio Salas García
José Luis González-Llerena
María Julia Verde-Star
Anthonny Cordero-Díaz
Michel Stéphane Heya
author_facet Manuel López-Cabanillas Lomelí
Alexandra Tijerina-Sáenz
David Gilberto García-Hernández
Marcelo Hernández-Salazar
Rogelio Salas García
José Luis González-Llerena
María Julia Verde-Star
Anthonny Cordero-Díaz
Michel Stéphane Heya
author_sort Manuel López-Cabanillas Lomelí
collection DOAJ
description Colon cancer (CC) is the third most frequent neoplasm, with a considerably high mortality rate. Due to the side effects of conventional forms of CC treatment (surgery, chemotherapy, and radiotherapy), several studies have focused on the use of medicinal plant derivatives to provide a green therapy for CC; although phytochemicals have shown promising results against CC, translating the results obtained in vitro and in vivo to the clinical setting remains a challenge. Indeed, like other orally applied medicines, medicinal plant derivatives have to cross different physiological barriers to reach the CC microenvironment, which considerably limits their dose-dependent therapeutic efficacy. On the other hand, phytocompounds are not free from biopharmaceutical drawbacks, so novel strategies using nanoparticles (NPs) have been proposed to overcome the physiological barriers of the body and provide controlled release of actives of interest. Accordingly, the current review provides an overview and discussion on the predisposing factors to CC and conventional treatment, the use of medicinal plants in CC treatment, and the advantages provided by NPs in the treatment of CC.
format Article
id doaj-art-fa5730e6b7dc4ab2b630c020075dc1de
institution Kabale University
issn 0036-8709
2218-0532
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Scientia Pharmaceutica
spelling doaj-art-fa5730e6b7dc4ab2b630c020075dc1de2025-08-20T03:44:04ZengMDPI AGScientia Pharmaceutica0036-87092218-05322024-12-01931110.3390/scipharm93010001Colon Cancer: Overview on Improved Therapeutic Potential of Plant-Based Compounds Using NanotechnologyManuel López-Cabanillas Lomelí0Alexandra Tijerina-Sáenz1David Gilberto García-Hernández2Marcelo Hernández-Salazar3Rogelio Salas García4José Luis González-Llerena5María Julia Verde-Star6Anthonny Cordero-Díaz7Michel Stéphane Heya8Facultad de Salud Pública y Nutrición, Universidad Autónoma de Nuevo León, Ave. Pedro de Alba S/N & Ave. Manuel L. Barragán, San Nicolas de los Garza 64460, Nuevo León, MexicoFacultad de Salud Pública y Nutrición, Universidad Autónoma de Nuevo León, Ave. Pedro de Alba S/N & Ave. Manuel L. Barragán, San Nicolas de los Garza 64460, Nuevo León, MexicoFacultad de Ciencias Biológicas, Departamento de Química, Universidad Autónoma de Nuevo León, San Nicolás de los Garza 66455, Nuevo León, MexicoFacultad de Salud Pública y Nutrición, Universidad Autónoma de Nuevo León, Ave. Pedro de Alba S/N & Ave. Manuel L. Barragán, San Nicolas de los Garza 64460, Nuevo León, MexicoFacultad de Salud Pública y Nutrición, Universidad Autónoma de Nuevo León, Ave. Pedro de Alba S/N & Ave. Manuel L. Barragán, San Nicolas de los Garza 64460, Nuevo León, MexicoFacultad de Salud Pública y Nutrición, Universidad Autónoma de Nuevo León, Ave. Pedro de Alba S/N & Ave. Manuel L. Barragán, San Nicolas de los Garza 64460, Nuevo León, MexicoFacultad de Ciencias Biológicas, Departamento de Química, Universidad Autónoma de Nuevo León, San Nicolás de los Garza 66455, Nuevo León, MexicoFacultad de Ciencias Químicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza 66455, Nuevo León, MexicoFacultad de Salud Pública y Nutrición, Universidad Autónoma de Nuevo León, Ave. Pedro de Alba S/N & Ave. Manuel L. Barragán, San Nicolas de los Garza 64460, Nuevo León, MexicoColon cancer (CC) is the third most frequent neoplasm, with a considerably high mortality rate. Due to the side effects of conventional forms of CC treatment (surgery, chemotherapy, and radiotherapy), several studies have focused on the use of medicinal plant derivatives to provide a green therapy for CC; although phytochemicals have shown promising results against CC, translating the results obtained in vitro and in vivo to the clinical setting remains a challenge. Indeed, like other orally applied medicines, medicinal plant derivatives have to cross different physiological barriers to reach the CC microenvironment, which considerably limits their dose-dependent therapeutic efficacy. On the other hand, phytocompounds are not free from biopharmaceutical drawbacks, so novel strategies using nanoparticles (NPs) have been proposed to overcome the physiological barriers of the body and provide controlled release of actives of interest. Accordingly, the current review provides an overview and discussion on the predisposing factors to CC and conventional treatment, the use of medicinal plants in CC treatment, and the advantages provided by NPs in the treatment of CC.https://www.mdpi.com/2218-0532/93/1/1colorectal cancerphytochemicalstherapeutic efficacyphysiological barriersnanoparticles
spellingShingle Manuel López-Cabanillas Lomelí
Alexandra Tijerina-Sáenz
David Gilberto García-Hernández
Marcelo Hernández-Salazar
Rogelio Salas García
José Luis González-Llerena
María Julia Verde-Star
Anthonny Cordero-Díaz
Michel Stéphane Heya
Colon Cancer: Overview on Improved Therapeutic Potential of Plant-Based Compounds Using Nanotechnology
Scientia Pharmaceutica
colorectal cancer
phytochemicals
therapeutic efficacy
physiological barriers
nanoparticles
title Colon Cancer: Overview on Improved Therapeutic Potential of Plant-Based Compounds Using Nanotechnology
title_full Colon Cancer: Overview on Improved Therapeutic Potential of Plant-Based Compounds Using Nanotechnology
title_fullStr Colon Cancer: Overview on Improved Therapeutic Potential of Plant-Based Compounds Using Nanotechnology
title_full_unstemmed Colon Cancer: Overview on Improved Therapeutic Potential of Plant-Based Compounds Using Nanotechnology
title_short Colon Cancer: Overview on Improved Therapeutic Potential of Plant-Based Compounds Using Nanotechnology
title_sort colon cancer overview on improved therapeutic potential of plant based compounds using nanotechnology
topic colorectal cancer
phytochemicals
therapeutic efficacy
physiological barriers
nanoparticles
url https://www.mdpi.com/2218-0532/93/1/1
work_keys_str_mv AT manuellopezcabanillaslomeli coloncanceroverviewonimprovedtherapeuticpotentialofplantbasedcompoundsusingnanotechnology
AT alexandratijerinasaenz coloncanceroverviewonimprovedtherapeuticpotentialofplantbasedcompoundsusingnanotechnology
AT davidgilbertogarciahernandez coloncanceroverviewonimprovedtherapeuticpotentialofplantbasedcompoundsusingnanotechnology
AT marcelohernandezsalazar coloncanceroverviewonimprovedtherapeuticpotentialofplantbasedcompoundsusingnanotechnology
AT rogeliosalasgarcia coloncanceroverviewonimprovedtherapeuticpotentialofplantbasedcompoundsusingnanotechnology
AT joseluisgonzalezllerena coloncanceroverviewonimprovedtherapeuticpotentialofplantbasedcompoundsusingnanotechnology
AT mariajuliaverdestar coloncanceroverviewonimprovedtherapeuticpotentialofplantbasedcompoundsusingnanotechnology
AT anthonnycorderodiaz coloncanceroverviewonimprovedtherapeuticpotentialofplantbasedcompoundsusingnanotechnology
AT michelstephaneheya coloncanceroverviewonimprovedtherapeuticpotentialofplantbasedcompoundsusingnanotechnology